Minimize Hair Loss
Comfortably. Conveniently. Confidently.

Breast cancer patients undergoing chemotherapy have faced the almost inevitable prospect of losing their hair. While scalp cooling during chemotherapy has long been known as an effective method to help to prevent that hair loss, U.S. patients have never had access to a scalp cooling treatment that is cleared by the FDA.  That has now changed.

For the first time ever the FDA has given clearance to a scalp cooling system that can reduce chemotherapy-induced hair loss in women with breast cancer: The DigniCap® scalp cooling system.

For over a decade, the DigniCap® system has successfully helped thousands of patients outside the United States. Now, with FDA clearance, infusion centers across the country will be able to offer this important treatment option directly to U.S. patients as part of their chemotherapy treatment.

DigniCap® scalp cooling systems are already in many infusion centers across the country, with more being added every week.  Patients should talk with their physicians and infusion centers in their area to explore adding the DigniCap® treatment to their chemotherapy regimen. Click here for an updated of list of infusion centers offering the DigniCap® treatment.

Featured Content from The Journal of the American Medical Association Network

Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer   JAMA Feb 14, 2017  by Hope S. Rugo, MD; Paula Klein, MD, Susan Anitra Melin, MD; et al

Scalp Cooling to Prevent Chemotherapy-Induced Alopecia: The Time Has Come   JAMA Feb 14, 2017 by Dawn L. Hershman, MD MS

Do the Data on Scalp Cooling for Patients with Breast Cancer Warrant Broad Adoption? JAMA Feb 14, 2017 by Howard (Jack) West, MD

Chemotherapy and Hair Loss: JAMA Patient Page   JAMA Feb 14, 2017 by Christopher Muth, MD

Download the DigniCap App